Shafi S, Ahmed Khan M, Ahmad J, Rabbani S, Singh S, Najmi A
Curr Drug Targets. 2024; 26(2):109-131.
PMID: 39377414
DOI: 10.2174/0113894501335877240926101134.
Daida T, Shin B, Cepeda C, Devaskar S
Nutrients. 2024; 16(14).
PMID: 39064806
PMC: 11279700.
DOI: 10.3390/nu16142363.
Goyal P, Malviya R
Endocr Metab Immune Disord Drug Targets. 2023; 24(5):549-561.
PMID: 37861029
DOI: 10.2174/0118715303256582230919093535.
Gumus E, Ozen H
World J Gastroenterol. 2023; 29(25):3932-3963.
PMID: 37476587
PMC: 10354582.
DOI: 10.3748/wjg.v29.i25.3932.
Lu X, Huang L, Chen Y, Ling Hu , Zhong R, Chen L
Foods. 2023; 12(8).
PMID: 37107484
PMC: 10137559.
DOI: 10.3390/foods12081687.
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy.
Puris E, Fricker G, Gynther M
Pharmaceutics. 2023; 15(2).
PMID: 36839686
PMC: 9966068.
DOI: 10.3390/pharmaceutics15020364.
Reprogramming of glucose metabolism in virus infected cells.
Goyal P, Rajala M
Mol Cell Biochem. 2023; 478(11):2409-2418.
PMID: 36709223
PMC: 9884135.
DOI: 10.1007/s11010-023-04669-4.
SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives.
Dutka M, Bobinski R, Francuz T, Garczorz W, Zimmer K, Ilczak T
Cancers (Basel). 2022; 14(23).
PMID: 36497303
PMC: 9738342.
DOI: 10.3390/cancers14235811.
Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.
Silva I, Kimura C, Colantoni V, Sogayar M
Stem Cell Res Ther. 2022; 13(1):309.
PMID: 35840987
PMC: 9284809.
DOI: 10.1186/s13287-022-02977-y.
Proteomic Changes to the Updated Discovery of Engineered Insulin and Its Analogs: Pros and Cons.
Hanif N, Wu H, Xu P, Li Y, Bibi A, Zulfiqar A
Curr Issues Mol Biol. 2022; 44(2):867-888.
PMID: 35723344
PMC: 8929101.
DOI: 10.3390/cimb44020059.
Exosome-Mediated Insulin Delivery for the Potential Treatment of Diabetes Mellitus.
Rodriguez-Morales B, Antunes-Ricardo M, Gonzalez-Valdez J
Pharmaceutics. 2021; 13(11).
PMID: 34834285
PMC: 8621140.
DOI: 10.3390/pharmaceutics13111870.
Functional Expression of the Human Glucose Transporters GLUT2 and GLUT3 in Yeast Offers Novel Screening Systems for GLUT-Targeting Drugs.
Schmidl S, Tamayo Rojas S, Iancu C, Choe J, Oreb M
Front Mol Biosci. 2021; 7:598419.
PMID: 33681287
PMC: 7930720.
DOI: 10.3389/fmolb.2020.598419.
Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review.
Pezzuto A, DAscanio M, Ricci A, Pagliuca A, Carico E
Thorac Cancer. 2020; 11(11):3060-3070.
PMID: 32945604
PMC: 7606016.
DOI: 10.1111/1759-7714.13651.
Fanconi-Bickel Syndrome: A Review of the Mechanisms That Lead to Dysglycaemia.
Sharari S, Abou-Alloul M, Hussain K, Khan F
Int J Mol Sci. 2020; 21(17).
PMID: 32877990
PMC: 7504390.
DOI: 10.3390/ijms21176286.
Glucose transporters in the small intestine in health and disease.
Koepsell H
Pflugers Arch. 2020; 472(9):1207-1248.
PMID: 32829466
PMC: 7462918.
DOI: 10.1007/s00424-020-02439-5.
Tracking the carbons supplying gluconeogenesis.
Shah A, Wondisford F
J Biol Chem. 2020; 295(42):14419-14429.
PMID: 32817317
PMC: 7573258.
DOI: 10.1074/jbc.REV120.012758.
Heterogeneity of Glucose Transport in Lung Cancer.
Martinez C, Scafoglio C
Biomolecules. 2020; 10(6).
PMID: 32517099
PMC: 7356687.
DOI: 10.3390/biom10060868.
A comprehensive overview of substrate specificity of glycoside hydrolases and transporters in the small intestine : "A gut feeling".
Elferink H, Bruekers J, Veeneman G, Boltje T
Cell Mol Life Sci. 2020; 77(23):4799-4826.
PMID: 32506169
PMC: 7658089.
DOI: 10.1007/s00018-020-03564-1.
Emerging roles of aerobic glycolysis in breast cancer.
Wu Z, Wu J, Zhao Q, Fu S, Jin J
Clin Transl Oncol. 2019; 22(5):631-646.
PMID: 31359335
DOI: 10.1007/s12094-019-02187-8.
Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation.
Hung M, Chen Y, Chen L, Chu P, Hsieh F, Tsai M
Cell Death Dis. 2019; 10(6):420.
PMID: 31142735
PMC: 6541593.
DOI: 10.1038/s41419-019-1646-6.